Celularity Inc. announced an exclusive manufacturing and commercial collaboration with Vesalius Longevity Labs Inc. on October 29, 2026. Under the agreement, Celularity will serve as the exclusive partner for the finish manufacturing of Vesalius’s Peptual peptide APIs. The